Platelet-activating factor mediates hemodynamic changes and lung injury in endotoxin-treated rats.
Open Access
- 1 May 1987
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 79 (5) , 1498-1509
- https://doi.org/10.1172/jci112980
Abstract
Within 20 min after intraperitoneal injection of Salmonella enteritidis endotoxin in rats, blood platelet-activating factor (PAF) increased from 4.3 +/- 1.3 to 13.7 +/- 2.0 ng/ml (P less than 0.01) and lung PAF from 32.3 +/- 4.9 to 312.3 +/- 19.6 ng (P less than 0.01), but not lung lavage PAF. We tested the effect of PAF receptor antagonists, CV 3988 and SRI 63-441, on endotoxin-induced hemodynamic changes and lung vascular injury. Pretreatment with CV 3988 attenuated systemic hypotension, preserved hypoxic pulmonary vasoconstriction, and prolonged survival of awake catheter-implanted endotoxin-treated (20 mg/kg) rats. Pretreatment with SRI 63-441 prevented the depressed hypoxic pulmonary vasoconstriction after low dose (2 mg/kg) endotoxin. Both CV 3988 and SRI 63-441 blocked the increased extravascular accumulation of 125I-albumin and water in perfused lungs isolated from endotoxin-treated rats. We conclude that PAF is produced in the lung during endotoxemia and may be an important mediator of the systemic and pulmonary hemodynamic changes as well as the acute lung vascular injury after endotoxemia.This publication has 55 references indexed in Scilit:
- Association of Platelet-Activating Factor with Primary Acquired Cold UrticariaNew England Journal of Medicine, 1985
- Production of peptide leukotrienes in endotoxin shockFEBS Letters, 1985
- Release of platelet-activating factor, slow-reacting substance, and vasoactive amines from isolated rat kidneysKidney International, 1984
- Platelet activating factor (PAF-acether) is released into rat pulmonary alveolar fluid as a consequence of hypoxiaBiochemical and Biophysical Research Communications, 1984
- Thromboxane A2 mediates lung vasoconstriction but not permeability after endotoxin.Journal of Clinical Investigation, 1983
- CV-3988 - A specific antagonist of platelet activating factor (PAF)Life Sciences, 1983
- Acetyl glyceryl ether phosphorylcholine-stimulated human platelets cause pulmonary hypertension and edema in isolated rabbit lungs. Role of thromboxane A2.Journal of Clinical Investigation, 1983
- Hypotensive activity of PAF-acether in ratsInflammation Research, 1982
- Elevated Thromboxane Levels in the Rat during Endotoxic ShockJournal of Clinical Investigation, 1980
- A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATIONCanadian Journal of Biochemistry and Physiology, 1959